Becton, Dickinson and Company BDX, popularly known as BD, is evaluating the divestment of its Life Sciences division as part ...

"Becton, Dickinson and Company (NYSE:BDX) is a US-based medical device company with USD 20 billion in revenue. A staple in our portfolio for 18 years, BD produces essential consumables like syringes ...

The owner of a Covington sterilization facility exposed the community with a carcinogenic gas for more than 50 years without warning the public, an attorney for a man suing the company told jurors ...

FRANKLIN LAKES, N.J., March 27, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Gregory J.

Becton, Dickinson and Company develops ... and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Company inaugurates groundbreaking Training Center in Riyadh, empowering healthcare professionals with advanced education, ...

Shares of Becton Dickinson & Co. BDX advanced 1.34% to $201.78 Friday, on what proved to be an all-around favorable trading ...

Barclays lowered the firm’s price target on Becton Dickinson (BDX) to $261 from $279 and keeps an Overweight rating on the shares. The firm ...

This was the stock's third consecutive day of losses.

The Saudi entity of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, successfully ...